GT Biopharma, Inc.
GTBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000109657
No open-market purchases or sales by GT Biopharma, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $1.02M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in GT Biopharma, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +1 vs. Q3 2023
- Shares held
- 3.44M
- +361 (0.0%) vs. Q3 2023
- Total value
- $893.1K
- +$43.2K (+5.1%) vs. Q3 2023
- New holders
- 6
- 8 more added
- Sold out
- 5
- 6 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GTBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $1.02M |
| Q1 2026 | 42 | $656.7K |
| Q4 2025 | 38 | $373.7K |
| Q3 2025 | 21 | $222.2K |
| Q2 2025 | 21 | $711.3K |
| Q1 2025 | 20 | $220.5K |
| Q4 2024 | 19 | $279.1K |
| Q3 2024 | 16 | $203.8K |
| Q2 2024 | 17 | $296.8K |
| Q1 2024 | 17 | $348.6K |
| Q4 2023 | 34 | $893.1K |
| Q3 2023 | 33 | $849.9K |
| Q2 2023 | 37 | $1.11M |
| Q1 2023 | 36 | $3.05M |
| Q4 2022 | 36 | $5.62M |
| Q3 2022 | 35 | $4.36M |
| Q2 2022 | 48 | $9.28M |
| Q1 2022 | 58 | $12.9M |
| Q4 2021 | 55 | $16.7M |
| Q3 2021 | 54 | $32.1M |
| Q2 2021 | 50 | $69.9M |
| Q1 2021 | 21 | $3.98M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding GT Biopharma, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,087,993 | $277.4K | 0.00% | +759+0.1% | Added |
| Bank of Montreal | 596,240 | $169.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 337,315 | $86.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 304,041 | $77.5K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 300,719 | $76.7K | 0.00% | +220.0% | Added |
| Renaissance Technologies LLC | 114,695 | $29.0K | 0.00% | +47,995+72.0% | Added |
| Atria Wealth Solutions, Inc. | 98,720 | $25.2K | 0.00% | +10,000+11.3% | Added |
| Bank of New York Mellon Corp | 95,239 | $24.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 79,976 | $20.4K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 65,953 | $16.8K | 0.00% | −22,056−25.1% | Reduced |
| Citadel Advisors LLC | 57,807 | $14.7K | 0.00% | +57,807 | New |
| Two Sigma Securities, LLC | 37,180 | $9.48K | 0.00% | +6,221+20.1% | Added |
| LPL Financial LLC | 34,320 | $8.75K | 0.00% | +34,320 | New |
| Northern Trust Corp | 32,347 | $8.25K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 33,785 | $8.00K | 0.00% | +33,785 | New |
| Marex Group plc | 30,000 | $7.65K | 0.00% | +30,000 | New |
| Goldman Sachs Group Inc | 22,867 | $5.83K | 0.00% | +12,443+119.4% | Added |
| Moss Adams Wealth Advisors LLC | 20,000 | $5.10K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 19,775 | $5.04K | 0.00% | −383−1.9% | Reduced |
| Jane Street Group, LLC | 19,405 | $4.95K | 0.00% | +19,405 | New |
| UBS Group AG | 14,605 | $3.72K | 0.00% | +5,855+66.9% | Added |
| Commonwealth Equity Services, LLC | 10,110 | $3.00K | 0.00% | 00.0% | Unchanged |
| Welch Group, LLC | 10,000 | $2.55K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8,078 | $2.06K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,073 | $273 | 0.00% | +565+111.2% | Added |
| Advisor Group Holdings, Inc. | 1,017 | $258 | 0.00% | −253−19.9% | Reduced |
| Blue Bell Private Wealth Management, LLC | 300 | $77 | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 150 | $38 | 0.00% | +150 | New |
| Front Row Advisors LLC | 58 | $15 | 0.00% | 00.0% | Unchanged |
| Retirement Group, LLC | 44 | $11 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 16 | $4 | 0.00% | −43−72.9% | Reduced |
| Qube Research & Technologies Ltd | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,197 | $0 | 0.00% | −239−9.8% | Reduced |
| Simplex Trading, LLC | 304 | $0 | 0.00% | −150−33.0% | Reduced |
| Baskin Financial Services Inc. | 0 | $0 | 0.00% | −151,354−100.0% | Sold out |
| Compagnie Lombard Odier SCmA | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −20,395−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,943−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |